Not content with getting the first lupus drug to market in the form of the blockbuster Benlysta more than a decade ago, GSK is handing over $300 million in upfront cash for a clinical-stage T-cell ...

Barclays lowered the firm’s price target on GSK (GSK) to 1,450 GBp from 1,550 GBp and keeps an Equal Weight rating on the shares.

GSK has struck a $2.2 billion agreement to settle the vast majority of U.S. lawsuits filed against it over claims its Zantac heartburn remedy causes cancer. The British drugmaker’s settlement ...

Haleon was spun off from GSK amid investor pressure, showing steady growth but facing debt concerns. See more about HLN stock ...

This writer thinks GSK shares appear very cheap after the Q3 results, making him wonder if now's the time for him to invest ...

Analysis of the full trial data, including the key secondary endpoint of overall survival (OS), is ongoing, but at the moment that data is “immature”, said GSK. In October, GSK reported new ...

Coolers full of vaccine strapped to their motorbikes ... mostly, as she is unable to form words. Her mother, Nazma, had been outside with the baby when we arrived; in these rooms nine families ...

GSK was able to avert industrial action at some of its UK facilities last year after agreeing a pay deal – but with the cost-of-living crisis still in full swing ... and other form of borrowing.

KellyFact checked by Vikki VelasquezAmerican taxpayers complain about a wide range of tax features but studies by the Pew Research Center consistently reveal that a majority express concern that some ...

In a dramatic turn of events that makes for some great storytelling, Cidara's novel drug-Fc conjugate, once locked up in a ...

Operator Good morning and good afternoon, and welcome to the Novartis Q3 2024 results release conference call and live ...